1. How to submit my research paper? What’s the process of publication of my paper?
The journal receives submitted manuscripts via email only. Please submit your research paper in .doc or.pdf format to the submission email: ijpmbs@ejournal.net.
You’ll be given a paper number if your submission is successful. Your paper then will undergo peer review process, which may take approximately one and a half months under normal circumstances, three tops.
After blind peer review, you will receive the notification letter with the review result of your paper...
2. Can I submit an abstract?
The journal publishes full research papers.[Read More]

Cardiomyogenic Differentiation of Fetal Derived Mesenchymal Stem Cells: A Transformative Approach for Cardiac Treatment

Shraddha Singh Gautam and Jaianand Kannaiyan
Stem Cell Division, Unistem Biosciences Pvt. Ltd., Gurgaon-122016, Haryana, India.

Abstract—There have been tremendous advances since past decade in the field of regeneration medicines with a hope of having potential to improve recovery from the most widespread diseases; cardiovascular disorder is one of them. Since then continuous preclinical and clinical trials have allowed to identify some important issues such as immune rejection, number of cells required, route of administration, engraftment, etc. These are to be addressed by appropriately focused bench work to find out a stem cell source having prerequisites as easily available, phenotypically well characterized, genotypically stable, consistent, scalable and sterile for an effective therapeutic application. In the current investigation we tested whether MSCs isolated from two fetal tissue sources such as Wharton's jelly and Umbilical cord blood can be coaxed in vitro into cardiomyogenic lineages with the exposure to 5' Azacytidine and whether regeneration of in vivo mouse myocardial infarcted heart is triggered by transplantation of these differentiated cells. Cardiac progenitor formation from guided in vitro MSC differentiation is the major determinant of in vivo cardiac regeneration in murine model. We could also observe that Wharton's Jelly is more potent source as compared to cord blood as far as extent of cardiac regeneration is considered.

Index Terms—Mesenchymal Stem Cells, In vitro Cardiomyogenic Differentiation, Engraftment, Cardiac Regeneration

Cite: Shraddha Singh Gautam and Jaianand Kannaiyan, "Cardiomyogenic Differentiation of Fetal Derived Mesenchymal Stem Cells: A Transformative Approach for Cardiac Treatment," International Journal of Pharma Medicine and Biological Sciences, Vol. 3, No. 1, pp. 85-98, January 2014.
Copyright © 2012-2024 International Journal of Pharma Medicine and Biological Sciences, All Rights Reserved
E-mail: ijpmbs@ejournal.net